Search Results - "GAJEWSKI, James L"

Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors by HAHN, Theresa, MCCARTHY, Philip L, LOBERIZA, Fausto, MAZIARZ, Richard T, RIZZO, J. Douglas, JOFFE, Steven, PARSONS, Susan, MAJHAIL, Navneet S, HASSEBROEK, Anna, BREDESON, Christopher, GAJEWSKI, James L, HALE, Gregory A, ISOLA, Luis M, LAZARUS, Hillard M, LEE, Stephanie J, LEMAISTRE, Charles F

“…Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases…”
Get full text

A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation by Gajewski, James L., Johnson, Viviana V., Sandler, S. Gerald, Sayegh, Antoine, Klumpp, Thomas R.

“…The increased use of hematopoietic progenitor cell (HPC) transplantation has implications and consequences for transfusion services: not only in hospitals…”
Get full text

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research by Keating, Armand, DaSilva, Gisela, Pérez, Waleska S, Gupta, Vikas, Cutler, Corey S, Ballen, Karen K, Cairo, Mitchell S, Camitta, Bruce M, Champlin, Richard E, Gajewski, James L, Lazarus, Hillard M, Lill, Michael, Marks, David I, Nabhan, Chadi, Schiller, Gary J, Socie, Gerald, Szer, Jeffrey, Tallman, Martin S, Weisdorf, Daniel J

“…The optimal post-remission treatment for acute myeloid leukemia in first complete remission remains uncertain. Previous comparisons of autologous versus…”
Get full text

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality by Khouri, Issa F., Saliba, Rima M., Giralt, Sergio A., Lee, Ming-Sheng, Okoroji, Grace-Julia, Hagemeister, Fredrick B., Korbling, Martin, Younes, Anas, Ippoliti, Cindy, Gajewski, James L., McLaughlin, Peter, Anderlini, Paolo, Donato, Michele L., Cabanillas, Fernando F., Champlin, Richard E.

“…This study investigated the use of a nonablative conditioning regimen to decrease toxicity and achieve engraftment of an allogeneic blood stem cell transplant,…”
Get full text

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years by Wong, Raymond, Giralt, Sergio A., Martin, Thomas, Couriel, Daniel R., Anagnostopoulos, Athanasios, Hosing, Chitra, Andersson, Borje S., Cano, Pedro, Shahjahan, Munir, Ippoliti, Cindy, Estey, Elihu H., McMannis, John, Gajewski, James L., Champlin, Richard E., de Lima, Marcos

“…Hematopoietic stem cell transplantation from unrelated donors is an effective treatment for myeloid malignancies, but its use is usually restricted to young…”
Get full text

Prevalence of Hematopoietic Cell Transplant Survivors in the United States by Majhail, Navneet S, Tao, Li, Bredeson, Christopher, Davies, Stella, Dehn, Jason, Gajewski, James L, Hahn, Theresa, Jakubowski, Ann, Joffe, Steven, Lazarus, Hillard M, Parsons, Susan K, Robien, Kim, Lee, Stephanie J, Kuntz, Karen M

“…Abstract Advances in hematopoietic cell transplantation (HCT) have led to an increasing number of transplant survivors. To adequately support their healthcare…”
Get full text

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors by Ueno, Naoto T., Cheng, Yee Chung, Rondón, Gabriela, Tannir, Nizar M., Gajewski, James L., Couriel, Daniel R., Hosing, Chitra, de Lima, Marcos J., Anderlini, Paolo, Khouri, Issa F., Booser, Daniel J., Hortobagyi, Gabriel N., Pagliaro, Lance C., Jonasch, Eric, Giralt, Sergio A., Champlin, Richard E.

“…We evaluated the feasibility and efficacy of a reduced-intensity conditioning (RIC) regimen of fludarabine and melphalan to achieve rapid complete donor…”
Get full text

Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial by Maziarz, Richard T, Devos, Timothy, Bachier, Carlos R, Goldstein, Steven C, Leis, Jose F, Devine, Steven M, Meyers, Gabrielle, Gajewski, James L, Maertens, Johan, Deans, Robert J, Van't Hof, Wouter, Lazarus, Hillard M

“…Abstract We conducted a multicenter, phase 1 dose escalation study evaluating the safety of the allogeneic multipotent adult progenitor cell (MAPC, MultiStem,…”
Get full text

Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients by Gajewski, James L., McClellan, Mark B., Majhail, Navneet S., Hari, Parameswaran N., Bredeson, Christopher N., Maziarz, Richard T., LeMaistre, Charles F., Lill, Michael C., Farnia, Stephanie H., Komanduri, Krishna V., Boo, Michael J.

“…•Patient-centered medical home models are fundamental to the advanced alternative payment models defined in MACRA statute.•The patient-centered medical home is…”
Get full text

Avascular Necrosis of Bone after Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents by Li, Xiaxin, Brazauskas, Ruta, Wang, Zhiwei, Al-Seraihy, Amal, Baker, K. Scott, Cahn, Jean-Yves, Frangoul, Haydar A, Gajewski, James L, Hale, Gregory A, Hsu, Jack W, Kamble, Rammurti T, Lazarus, Hillard M, Marks, David I, Maziarz, Richard T, Savani, Bipin N, Shah, Ami J, Shah, Nirali, Sorror, Mohamed L, Wood, William A, Majhail, Navneet S

“…Abstract We conducted a nested case-control study within a cohort of 6244 patients to assess risk factors for avascular necrosis (AVN) of bone in children and…”
Get full text

ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited by Seebach, Jörg D., Stussi, Georg, Passweg, Jakob R., Loberiza, Fausto R., Gajewski, James L., Keating, Armand, Goerner, Martin, Rowlings, Philip A., Tiberghien, Pierre, Elfenbein, Gerald J., Gale, Robert Peter, van Rood, Jon J., Reddy, Vijay, Gluckman, Eliane, Bolwell, Brian J., Klumpp, Thomas R., Horowitz, Mary M., Ringdén, Olle, Barrett, A. John

“…Reports have shown a worse outcome for donor-recipient pairs mismatched for ABO blood groups in bone marrow transplantation (BMT). These studies, however,…”
Get full text

Emergence of Cunninghamella As a Pathogenic Invasive Mold Infection in Allogeneic Transplant Recipients by Strasfeld, Lynne, Espinosa-Aguilar, Luis, Gajewski, James L, Stenzel, Peter, Pimentel, Agustin, Mater, Elana, Maziarz, Richard T

Get full text

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma by HORTOBAGYI, G. N, BUZDAR, A. U, GAJEWSKI, J. L, RONDON, G, SMITH, T. L, SINGLETARY, S. E, AMES, F. C, SNEIGE, N, STROM, E. A, MCNEESE, M. D, DEISSEROTH, A. B, CHAMPLIN, R. E, THERIAULT, R. L, VALERO, V, FRYE, D, BOOSER, D. J, HOLMES, F. A, GIRALT, S, KHOURI, I, ANDERSSON, B

“…Uncontrolled studies have reported encouraging outcomes for patients with high-risk primary breast cancer treated with high-dose chemotherapy and autologous…”
Get full text

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma : Follow-up at 12 years by HANRAHAN, Emer O, BROGLIO, Kristine, CHAMPLIN, Richard E, HORTOBAGYI, Gabriel N, FRYE, Deborah, BUZDAR, Aman U, THERIAULT, Richard L, VALERO, Vicente, BOOSER, Daniel J, SINGLETARY, Sonja E, STROM, Eric A, GAJEWSKI, James L

“…The authors previously reported results from a randomized trial of standard-dose chemotherapy with combined 5-fluorouracil (1000 mg/m2 per cycle), doxorubicin…”
Get full text

Autotransplants for Hodgkin's Disease in Patients Never Achieving Remission: A Report From the Autologous Blood and Marrow Transplant Registry by LAZARUS, H. M, ROWLINGS, P. A, MILLER, C. B, PHILLIPS, G. L, REECE, D. E, SOBOCINSKI, K. A, VAN BESIEN, K, HOROWITZ, M. M, ZHANG, M.-J, VOSE, J. M, ARMITAGE, J. O, BIERMAN, P. J, GAJEWSKI, J. L, GALE, R. P, KEATING, A, KLEIN, J. P

“…Hodgkin's disease patients who never achieve complete remission with conventional chemotherapy (i.e., those with primary induction failure) have a poor…”
Get full text

Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study by Reece, Donna E, Vesole, David H, Shrestha, Smriti, Zhang, Mei-Jie, Pérez, Waleska S, Dispenzieri, Angela, Milone, Gustavo A, Abidi, Muneer, Atkins, Harold, Bashey, Asad, Bredeson, Christopher N, Boza, Willem Bujan, Freytes, César O, Gale, Robert Peter, Gajewski, James L, Gibson, John, Hale, Gregory A, Kumar, Shaji, Kyle, Robert A, Lazarus, Hillard M, McCarthy, Philip L, Pavlovsky, Santiago, Roy, Vivek, Weisdorf, Daniel J, Wiernik, Peter H, Hari, Parameswaran N

“…Abstract Introduction Immunoglobulin D (IgD) and IgM multiple myeloma represent uncommon immunoglobulin isotypes, accounting for 2% and 0.5% of cases,…”
Get full text

Response to Letter from Demetrios S. Theodoropoulos, MD, DSc by Gajewski, James L., MD, FACP, Lill, Michael, MD, Horowitz, Mary, MD, Maziarz, Richard T., MD

Get full text

Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation by Wirk, Baldeep, Klumpp, Thomas R., Ulicny, John, Herman, Jay H., Gajewski, James L., Martin, Mary E., Emmons, Robert V.B., Mangan, Kenneth F.

“…BACKGROUND: A recently published study has reported that donor‐recipient Rhesus (Rh)‐mismatched allogeneic hematopoietic stem cell transplantation…”
Get full text

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity by Gopal, Ramesh, Ha, Chul S., Tucker, Susan L., Khouri, Issa F., Giralt, Sergio A., Gajewski, James L., Andersson, Borje S., Cox, James D., Champlin, Richard E.

“…BACKGROUND Total body irradiation (TBI) is commonly used with autologous bone marrow transplantation (BMT) for treatment of hematologic malignancies. Pulmonary…”
Get full text

Randomized trial of high‐dose chemotherapy and autologous hematopoietic stem cell support for high‐risk primary breast carcinoma by Hanrahan, Emer O., Broglio, Kristine, Frye, Deborah, Buzdar, Aman U., Theriault, Richard L., Valero, Vicente, Booser, Daniel J., Singletary, Sonja E., Strom, Eric A., Gajewski, James L., Champlin, Richard E., Hortobagyi, Gabriel N.

“…BACKGROUND The authors previously reported results from a randomized trial of standard‐dose chemotherapy with combined 5‐fluorouracil (1000 mg/m2 per cycle),…”
Get full text